Predicting the Molecular Mechanism of Shenling Baizhu San in Treating Convalescent Patients With COVID-19 Based on Network Pharmacology and Molecular Docking

Ying Zhang(Hubei University of Chinese Medicine), Yanfang Yang(Beijing Normal University), Lu Li(California University of Pennsylvania), YiWen Liu(Hubei University of Chinese Medicine)
Natural Product Communications
October 1, 2021
10.1177/1934578x211046069
Cited by 2

Related Papers

New advances of adiponectin in regulating obesity and related metabolic syndromes
|Journal of Pharmaceutical Analysis|2023|81
Efficacy and Safety of Triazavirin Therapy for Coronavirus Disease 2019: A Pilot Randomized Controlled Trial
|Engineering|2020|59
Prevalence and clinical features of 2019 novel coronavirus disease (COVID-19) in the Fever Clinic of a teaching hospital in Beijing: a single-center, retrospective study
|medRxiv|2020|37
Leveraging network pharmacology for drug discovery: Integrative approaches and emerging insights
|Medicine in Drug Discovery|2025|36
Inhibition of Advanced Glycation End Product Formation by Pu-erh Tea Ameliorates Progression of Experimental Diabetic Nephropathy
|Journal of Agricultural and Food Chemistry|2012|33